Search Ontology:
ChEBI
mupirocin
- Term ID
- CHEBI:7025
- Synonyms
-
- 9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid
- Bactroban
- Centany
- mupirocin
- mupirocina
- mupirocine
- mupirocinum
- Pseudomonic acid A
- Definition
- An alpha,beta-unsaturated ester resulting from the formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with the carboxy group of (2E)-4-[(2S)-tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoic acid in which the tetrahydropyranyl ring is substituted at positions 3 and 4 by hydroxy groups and at position 5 by a {(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl group. Originally isolated from the Gram-negative bacterium Pseudomonas fluorescens, it is used as a topical antibiotic for the treatment of Gram-positive bacterial infections.
- References
-
- CAS:12650-69-0
- DrugBank:DB00410
- Drug_Central:1857
- HMDB:HMDB0014554
- KEGG:D01076
- PMID:22500807
- PMID:23337107
- PMID:23535880
- PMID:23543635
- PMID:24625190
- PMID:3101012
- Patent:DE2227739
- Patent:US3977943
- Patent:US4071536
- Wikipedia:Mupirocin
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
- has_role
-
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Phenotype
Phenotype resulting from mupirocin
Phenotype where environments contain mupirocin
Phenotype modified by environments containing mupirocin
Human Disease Model